Zenotech Laboratories

Zenotech Laboratories Pre-Tax Margin

The Pre-Tax Profit Margin of Zenotech Laboratories (532039.BO) as of Nov 22, 2026 is 10.59 %. In the previous year, Pre-Tax Profit Margin was 24.84 % — a change of -57.37% (lower).

Pre-Tax Margin

10.59 %

YoY

-57.37%

Last updated:

Pre-Tax Profit Margin of Zenotech Laboratories is 2026 10.59 % . Pre-Tax Profit Margin of Zenotech Laboratories was 2025 24.84 % . It decreases by -57.37% lower compared to the previous year.

The Zenotech Laboratories Pre-Tax Margin history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Pre-Tax Margin
Date
Pre-Tax Margin
Jan 1, 2019
-24.00 INR
Jan 1, 2020
41.55 INR
Jan 1, 2021
-6.27 INR
Jan 1, 2022
27.08 INR
Jan 1, 2023
34.18 INR
Jan 1, 2024
27.29 INR
Jan 1, 2025
24.84 INR
Jan 1, 2026
10.59 INR
The Zenotech Laboratories Pre-Tax Margin history
YEARPre-Tax MarginYoY
10.59 %-57.37%
24.84 %-8.97%
27.29 %-20.18%
34.18 %+26.24%
27.08 %-531.73%
-6.27 %-115.09%
41.55 %-273.13%
-24.00 %-77.43%
-106.34 %-87.93%
-881.41 %+0.74%
-874.97 %+77.70%
-492.39 %-49.92%
-983.17 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Zenotech Laboratories Stock analysis

What does Zenotech Laboratories do? Zenotech Laboratories Ltd manufactures and markets pharmaceutical products, specializing in oncology, biotechnology, and general injectables. The company operates from a manufacturing facility in Turkapally village, Shamirpet Mandal, Telangana, producing specialty generic injectables for the pharmaceutical sector. Its products are sold to healthcare providers and distributors within the pharmaceutical industry, targeting markets that require specialized injectable solutions. The firm's business model focuses on the production and distribution of generic injectables, leveraging its facility in Telangana to serve both domestic and international markets. By concentrating on oncology and biotechnology injectables, Zenotech addresses specific medical needs, generating revenue through the sale of these high-demand pharmaceutical products to hospitals, clinics, and pharmaceutical distributors. Zenotech Laboratories Ltd's revenue streams come from the sale of its specialty generic injectables, including oncology and biotechnology products, to healthcare institutions and distribution networks. The company's manufacturing capabilities in Telangana support its role as a supplier in the pharmaceutical supply chain, with a focus on injectable formulations that cater to critical healthcare applications. Zenotech Laboratories is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Zenotech Laboratories stock

Pre-Tax Profit Margin of Zenotech Laboratories is 10.59 % in 2026.

Pre-Tax Profit Margin of Zenotech Laboratories changed from 24.84 % to 10.59 %, representing a -57.37% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Pre-Tax Profit Margin Zenotech Laboratories since 2006 – with annual values, charts, and detailed analysis.

Pre-tax margin measures the percentage of revenue remaining after all expenses except income taxes. It isolates operational and financial performance from tax effects.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Pre-Tax Profit Margin's Zenotech Laboratories with sector peers and the industry average to assess whether it is attractive.

To evaluate Pre-Tax Profit Margin's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Pre-Tax Profit Margin.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Margins — Zenotech Laboratories

All Key Metrics — Zenotech Laboratories